Frederic Fahey

Publications

1. Review of the Clinical and Technical Aspects of 99mTc-Dimercaptosuccinic Acid Renal Imaging: The Comeback "Kit". J Nucl Med Technol. 2024 Sep 05; 52(3):199-204. View Abstract
2. A Call for Action on Patient Communication Efforts in Pediatric Radiology. J Am Coll Radiol. 2024 Jan; 21(1):44-45. View Abstract
3. Girth-based administered activity for pediatric 99m Tc-DMSA SPECT. Med Phys. 2024 Feb; 51(2):1019-1033. View Abstract
4. Fetal Dose from PET and CT in Pregnant Patients. J Nucl Med. 2023 02; 64(2):312-319. View Abstract
5. Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0. Eur J Nucl Med Mol Imaging. 2022 09; 49(11):3852-3869. View Abstract
6. Development and autoregulation of kidney function in children: a retrospective study using 99mTc-MAG3 renography. Pediatr Nephrol. 2022 09; 37(9):2157-2166. View Abstract
7. Radiation Dose to Pediatric Patients From Radiopharmaceuticals. Semin Nucl Med. 2022 03; 52(2):149-156. View Abstract
8. Impact of reconstruction parameters on lesion detection and localization in joint ictal/inter-ictal SPECT reconstruction. Ann Nucl Med. 2022 Jan; 36(1):24-32. View Abstract
9. PET/computed tomography in inpatients: part 1, international survey. Nucl Med Commun. 2021 Sep 01; 42(9):1045-1051. View Abstract
10. Renal 99mTc-DMSA pharmacokinetics in pediatric patients. EJNMMI Phys. 2021 Jul 20; 8(1):53. View Abstract
11. Residency training for diagnostic imaging physicists should be expanded to include nuclear medicine physics. Med Phys. 2021 Aug; 48(8):4123-4126. View Abstract
12. Detecting lumbar lesions in 99m Tc-MDP SPECT by deep learning: Comparison with physicians. Med Phys. 2021 Aug; 48(8):4249-4261. View Abstract
13. Response to Febo-Rodriguez et al. Am J Gastroenterol. 2021 07 01; 116(7):1553. View Abstract
14. Developing and implementing a multi-modality imaging optimization study in paediatric radiology: Experience and recommendations from an IAEA coordinated research project. Phys Med. 2021 Feb; 82:255-265. View Abstract
15. DeepAMO: a multi-slice, multi-view anthropomorphic model observer for visual detection tasks performed on volume images. J Med Imaging (Bellingham). 2021 Jul; 8(4):041204. View Abstract
16. Celebrating eighty years of radionuclide therapy and the work of Saul Hertz. J Appl Clin Med Phys. 2021 Jan; 22(1):4-10. View Abstract
17. Dosimetric considerations of 99mTc-MDP uptake within the epiphyseal plates of the long bones of pediatric patients. Phys Med Biol. 2020 12 02; 65(23):235025. View Abstract
18. Body morphometry appropriate computational phantoms for dose and risk optimization in pediatric renal imaging with Tc-99m DMSA and Tc-99m MAG3. Phys Med Biol. 2020 11 27; 65(23):235026. View Abstract
19. Pediatric Solid Gastric Emptying Scintigraphy: Normative Value Guidelines and Nonstandard Meal Alternatives. Am J Gastroenterol. 2020 11; 115(11):1830-1839. View Abstract
20. Developing and Implementing an Imaging Optimization Study in Pediatric Nuclear Medicine: Experience and Recommendations from an IAEA-Coordinated Research Project. J Nucl Med. 2021 04; 62(4):570-576. View Abstract
21. Pediatric Solid Gastric Emptying Scintigraphy: Normative Value Guidelines and Nonstandard Meal Alternatives. Am J Gastroenterol. 2020 Aug 19. View Abstract
22. Ethical aspects in the use of radiation in medicine: update from ICRP Task Group 109. Ann ICRP. 2020 Dec; 49(1_suppl):143-153. View Abstract
23. Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project. J Nucl Med. 2021 03; 62(3):422-430. View Abstract
24. Paediatric nuclear medicine practice: an international survey by the IAEA. Eur J Nucl Med Mol Imaging. 2020 06; 47(6):1552-1563. View Abstract
25. Current pediatric administered activity guidelines for 99m Tc-DMSA SPECT based on patient weight do not provide the same task-based image quality. Med Phys. 2019 Nov; 46(11):4847-4856. View Abstract
26. Update: Image Gently and Nuclear Medicine at 10 Years. J Nucl Med. 2019 Apr; 60(4):7N-9N. View Abstract
27. Dose Optimization of Hybrid Imaging. Health Phys. 2019 Feb; 116(2):179-183. View Abstract
28. Use of a Qualification Phantom for PET Brain Imaging in a Multicenter Consortium: A Collaboration Between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network. J Nucl Med. 2019 05; 60(5):677-682. View Abstract
29. Re-evaluation of pediatric 18F-FDG dosimetry: Cristy-Eckerman versus UF/NCI hybrid computational phantoms. Phys Med Biol. 2018 08 14; 63(16):165012. View Abstract
30. Establishing a Radiation Safety Credential for Nuclear Medicine Technologists. J Nucl Med Technol. 2018 Dec; 46(4):391-393. View Abstract
31. A projection image database to investigate factors affecting image quality in weight-based dosing: application to pediatric renal SPECT. Phys Med Biol. 2018 07 09; 63(14):145004. View Abstract
32. Standardization of Administered Activities in Pediatric Nuclear Medicine. J Am Coll Radiol. 2018 04; 15(4):695-696. View Abstract
33. Use of Monte Carlo Techniques in Nuclear Medicine. J Am Coll Radiol. 2018 03; 15(3 Pt A):446-448. View Abstract
34. How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting. Cancer Imaging. 2017 Nov 07; 17(1):28. View Abstract
35. Appropriate Use of Effective Dose in Radiation Protection and Risk Assessment. Health Phys. 2017 08; 113(2):102-109. View Abstract
36. Lassmann Recognized with Loevinger-Berman Award. J Nucl Med. 2017 08; 58(8):14N. View Abstract
37. Operational and Dosimetric Aspects of Pediatric PET/CT. J Nucl Med. 2017 09; 58(9):1360-1366. View Abstract
38. Stomach frame-count-based attenuation correction of dynamic posterior view gastric emptying scintigraphy with continuous acquisition in children. Pediatr Radiol. 2017 Nov; 47(12):1599-1607. View Abstract
39. Appropriate Use Criteria for Ventilation-Perfusion Imaging in Pulmonary Embolism: Summary and Excerpts. J Nucl Med. 2017 05; 58(5):13N-15N. View Abstract
40. Saul Hertz, MD, and the birth of radionuclide therapy. EJNMMI Phys. 2017 Dec; 4(1):15. View Abstract
41. Joint reconstruction of Ictal/inter-ictal SPECT data for improved epileptic foci localization. Med Phys. 2017 Apr; 44(4):1437-1444. View Abstract
42. Correlation of 18F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium. J Nucl Med. 2017 08; 58(8):1264-1269. View Abstract
43. History Corner: Archive Project and History Fund. J Nucl Med. 2017 01; 58(1):19N. View Abstract
44. 2016 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical Activities. J Nucl Med. 2016 12; 57(12):15N-18N. View Abstract
45. Dose Estimation in Pediatric Nuclear Medicine. Semin Nucl Med. 2017 03; 47(2):118-125. View Abstract
46. Targeted Radionuclide Therapy: Practical Applications and Future Prospects. Biomark Cancer. 2016; 8(Suppl 2):35-8. View Abstract
47. Administered Activities in Pediatric Nuclear Medicine and the Impact of the 2010 North American Consensus Guidelines on General Hospitals in the United States. J Nucl Med. 2016 09; 57(9):1478-85. View Abstract
48. Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 2-Current Standards and the Path Toward Global Standardization. J Nucl Med. 2016 Jul; 57(7):1148-57. View Abstract
49. Pharmacokinetic modeling of [(18)F]fluorodeoxyglucose (FDG) for premature infants, and newborns through 5-year-olds. EJNMMI Res. 2016 Dec; 6(1):28. View Abstract
50. The Current State of Nuclear Medicine Physics Training: Findings of the AAPM/SNMMI Task Force. J Nucl Med. 2016 07; 57(7):1146-7. View Abstract
51. A risk index for pediatric patients undergoing diagnostic imaging with (99m)Tc-dimercaptosuccinic acid that accounts for body habitus. Phys Med Biol. 2016 Mar 21; 61(6):2319-32. View Abstract
52. MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy. J Nucl Med. 2016 Jan; 57(1):151-62. View Abstract
53. Role of Reference Levels in Nuclear Medicine: A Report of the SNMMI Dose Optimization Task Force. J Nucl Med. 2015 Dec; 56(12):1960-4. View Abstract
54. AAPM/SNMMI Joint Task Force: report on the current state of nuclear medicine physics training. J Appl Clin Med Phys. 2015 09 08; 16(5):3-13. View Abstract
55. Use of [18F]FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft Rejection. Transplantation. 2015 Sep; 99(9):e132-9. View Abstract
56. AAPM/SNMMI Joint Task Force: report on the current state of nuclear medicine physics training. J Appl Clin Med Phys. 2015 Sep; 16(5):3-13. View Abstract
57. A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors. Childs Nerv Syst. 2015 Sep; 31(9):1433-45. View Abstract
58. (18)F-labeled rhodamines as potential myocardial perfusion agents: comparison of pharmacokinetic properties of several rhodamines. Nucl Med Biol. 2015 Oct; 42(10):796-803. View Abstract
59. MO-DE-201-03. Med Phys. 2015 Jun; 42(6):3559. View Abstract
60. Proceedings of the Second NCI-SNMMI Workshop on Targeted Radionuclide Therapy. J Nucl Med. 2015 Jul; 56(7):1119-29. View Abstract
61. Effects of Image Gently and the North American guidelines: administered activities in children at 13 North American pediatric hospitals. J Nucl Med. 2015 Jun; 56(6):962-7. View Abstract
62. History Corner: from the new SNMMI historian. J Nucl Med. 2015 Apr; 56(4):11N. View Abstract
63. Standardization of administered activities in pediatric nuclear medicine: a report of the first nuclear medicine global initiative project, part 1-statement of the issue and a review of available resources. J Nucl Med. 2015 Apr; 56(4):646-51. View Abstract
64. Radiation doses for pediatric nuclear medicine studies: comparing the North American consensus guidelines and the pediatric dosage card of the European Association of Nuclear Medicine. Pediatr Radiol. 2015 Apr; 45(5):706-13. View Abstract
65. Beyond current guidelines: reduction in minimum administered radiopharmaceutical activity with preserved diagnostic image quality in pediatric hepatobiliary scintigraphy. Eur J Nucl Med Mol Imaging. 2014 Dec; 41(12):2346-53. View Abstract
66. 18F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortium. J Nucl Med. 2014 Sep; 55(9):1473-80. View Abstract
67. In any use of ionizing radiation,consideration of the benefits of the exposures to possible risks is a central concern, for the physician and patient. Semin Nucl Med. 2014 May; 44(3):160-1. View Abstract
68. Dose optimization in nuclear medicine. Semin Nucl Med. 2014 May; 44(3):193-201. View Abstract
69. Pediatric nuclear medicine and radiation dose. Semin Nucl Med. 2014 May; 44(3):202-9. View Abstract
70. Targeted radionuclide therapy: proceedings of a joint workshop hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging. J Nucl Med. 2014 Feb; 55(2):337-48. View Abstract
71. Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study. Neuro Oncol. 2014 Jan; 16(2):310-7. View Abstract
72. Biological characterization of F-18-labeled rhodamine B, a potential positron emission tomography perfusion tracer. Nucl Med Biol. 2013 Nov; 40(8):1043-8. View Abstract
73. Radiation exposure to family caregivers and nurses of pediatric neuroblastoma patients receiving 131I-metaiodobenzylguanidine (131I-MIBG) therapy. Clin Nucl Med. 2013 Aug; 38(8):604-7. View Abstract
74. Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium. J Nucl Med. 2013 Aug; 54(8):1237-43. View Abstract
75. WE-E-137-01: RSO Refresher Training. Med Phys. 2013 Jun; 40(6Part29):487. View Abstract
76. WE-C-144-01: The Management of Imaging Procedure Dose 2: Nuclear Medicine. Med Phys. 2013 Jun; 40(6Part29):486. View Abstract
77. Specific uptake of 99mTc-NC100692, an avß3-targeted imaging probe, in subcutaneous and orthotopic tumors. Nucl Med Biol. 2013 Aug; 40(6):788-94. View Abstract
78. Effect of the prosthetic group on the pharmacologic properties of 18F-labeled rhodamine B, a potential myocardial perfusion agent for positron emission tomography (PET). J Med Chem. 2012 Dec 27; 55(24):11004-12. View Abstract
79. Promoting radiation dose optimization. J Nucl Med. 2012 Sep; 53(9):33N. View Abstract
80. Gastric emptying in children: what is the best acquisition method? J Pediatr Gastroenterol Nutr. 2012 Aug; 55(2):191-3. View Abstract
81. SNM leadership update: ensuring the health of our profession. J Nucl Med. 2012 Jul; 53(7):22N. View Abstract
82. Proposed name change for the society of nuclear medicine. J Nucl Med. 2012 May; 53(5):11N. View Abstract
83. [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation. J Neurooncol. 2012 Jul; 108(3):469-75. View Abstract
84. The voltage-gated proton channel Hv1 enhances brain damage from ischemic stroke. Nat Neurosci. 2012 Mar 04; 15(4):565-73. View Abstract
85. Minimizing and communicating radiation risk in pediatric nuclear medicine. J Nucl Med Technol. 2012 Mar; 40(1):13-24. View Abstract
86. Strengthening our profession through community and collaboration. J Nucl Med. 2012 Feb; 53(2):14N. View Abstract
87. Reduction in radiation dose in mercaptoacetyltriglycerine renography with enhanced planar processing. Radiology. 2011 Dec; 261(3):907-15. View Abstract
88. Iodine-131-labeled meta-iodobenzylguanidine therapy of children with neuroblastoma: program planning and initial experience. Semin Nucl Med. 2011 Sep; 41(5):354-63. View Abstract
89. Economic and radiation costs of initial imaging approaches after a child's first febrile urinary tract infection. Clin Pediatr (Phila). 2012 Jan; 51(1):23-30. View Abstract
90. Minimizing and communicating radiation risk in pediatric nuclear medicine. J Nucl Med. 2011 Aug; 52(8):1240-51. View Abstract
91. Nuclear medicine in the first year of life. J Nucl Med. 2011 Jun; 52(6):905-25. View Abstract
92. Improved quality of pediatric 123I-MIBG images with medium-energy collimators. J Nucl Med Technol. 2011 Jun; 39(2):100-4. View Abstract
93. Identifying ureteropelvic junction obstruction by fluorescence imaging: a comparative study of imaging modalities to assess renal function and degree of obstruction in a mouse model. J Urol. 2011 Jun; 185(6):2405-13. View Abstract
94. Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium. J Nucl Med. 2011 Feb; 52(2):188-95. View Abstract
95. Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody. Nucl Med Biol. 2011 Jan; 38(1):29-38. View Abstract
96. Costs and consequences of universal sibling screening for vesicoureteral reflux: decision analysis. Pediatrics. 2010 Nov; 126(5):865-71. View Abstract
97. Pediatric 99mTc-MDP bone SPECT with ordered subset expectation maximization iterative reconstruction with isotropic 3D resolution recovery. Radiology. 2010 Dec; 257(3):793-801. View Abstract
98. Detection of intestinal inflammation by MicroPET imaging using a (64)Cu-labeled anti-beta(7) integrin antibody. Inflamm Bowel Dis. 2010 Sep; 16(9):1458-66. View Abstract
99. Estimated cumulative radiation dose from PET/CT in children with malignancies. Pediatr Radiol. 2010 Oct; 40(10):1712-3; author reply 1714-5. View Abstract
100. Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis. Am J Pathol. 2010 Sep; 177(3):1459-69. View Abstract
101. Variability in PET quantitation within a multicenter consortium. Med Phys. 2010 Jul; 37(7):3660-6. View Abstract
102. Seasonal variation in the effect of constant ambient temperature of 24 degrees C in reducing FDG uptake by brown adipose tissue in children. Eur J Nucl Med Mol Imaging. 2010 Oct; 37(10):1854-60. View Abstract
103. Cheese is a reliable alternative meal for solid-phase gastric emptying study. Nucl Med Commun. 2010 May; 31(5):430-3. View Abstract
104. Biodistribution and stability studies of [18F]fluoroethylrhodamine B, a potential PET myocardial perfusion agent. Nucl Med Biol. 2010 Apr; 37(3):365-70. View Abstract
105. Use of (99m)Tc-MDP SPECT for assessment of mandibular growth: development of normal values. Eur J Nucl Med Mol Imaging. 2010 May; 37(5):1002-10. View Abstract
106. Synthesis of fluorine-18 labeled rhodamine B: A potential PET myocardial perfusion imaging agent. Appl Radiat Isot. 2010 Jan; 68(1):96-100. View Abstract
107. Dosimetry of Pediatric PET/CT. J Nucl Med. 2009 Sep; 50(9):1483-91. View Abstract
108. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature. 2009 Jul 09; 460(7252):259-63. View Abstract
109. Pediatric 99mTc-DMSA SPECT performed by using iterative reconstruction with isotropic resolution recovery: improved image quality and reduced radiopharmaceutical activity. Radiology. 2009 May; 251(2):511-6. View Abstract
110. Constant ambient temperature of 24 degrees C significantly reduces FDG uptake by brown adipose tissue in children scanned during the winter. Eur J Nucl Med Mol Imaging. 2009 Apr; 36(4):602-6. View Abstract
111. Pediatric radiation exposure and effective dose reduction during voiding cystourethrography. Radiology. 2008 Dec; 249(3):1002-9. View Abstract
112. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev. 2008 Jun 15; 22(12):1662-76. View Abstract
113. Administered radiopharmaceutical doses in children: a survey of 13 pediatric hospitals in North America. J Nucl Med. 2008 Jun; 49(6):1024-7. View Abstract
114. Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC). Eur J Nucl Med Mol Imaging. 2008 Sep; 35(9):1651-8. View Abstract
115. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med. 2008 Jan; 49(1):68-78. View Abstract
116. PET and PET/CT in pediatric oncology. Semin Nucl Med. 2007 Sep; 37(5):316-31. View Abstract
117. Early experience with fluorine-18 sodium fluoride bone PET in young patients with back pain. J Pediatr Orthop. 2007 Apr-May; 27(3):277-82. View Abstract
118. The Neuroimaging Center of the Pediatric Brain Tumor Consortium-collaborative neuroimaging in pediatric brain tumor research: a work in progress. AJNR Am J Neuroradiol. 2007 Apr; 28(4):603-7. View Abstract
119. Dosimetry and adequacy of CT-based attenuation correction for pediatric PET: phantom study. Radiology. 2007 Apr; 243(1):96-104. View Abstract
120. Evaluation of the quantitative capability of a high-resolution positron emission tomography scanner for small animal imaging. J Comput Assist Tomogr. 2004 Nov-Dec; 28(6):842-8. View Abstract
121. Standardization and quantification of radionuclide solid gastric-emptying studies. J Nucl Med. 2004 May; 45(5):760-4. View Abstract
122. Instrumentation in positron emission tomography. Neuroimaging Clin N Am. 2003 Nov; 13(4):659-69. View Abstract
123. Application of TACT to the evaluation of total joint arthroplasty. Med Phys. 2003 Mar; 30(3):454-60. View Abstract
124. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow. Anesth Analg. 2002 Oct; 95(4):1052-9, table of contents. View Abstract
125. Angular disparity in ETACT scintimammography. Med Phys. 2002 Sep; 29(9):1980-3. View Abstract
126. Data acquisition in PET imaging. J Nucl Med Technol. 2002 Jun; 30(2):39-49. View Abstract
127. Positron emission tomography instrumentation. Radiol Clin North Am. 2001 Sep; 39(5):919-29. View Abstract
128. Reduced regional and global cerebral blood flow during fenoldopam-induced hypotension in volunteers. Anesth Analg. 2001 Jul; 93(1):45-52. View Abstract
129. Emission tuned-aperture computed tomography: a novel approach to scintimammography. J Nucl Med. 2001 Jul; 42(7):1121-7. View Abstract
130. Cortical activity related to accuracy of letter recognition. Neuroimage. 2000 Feb; 11(2):111-23. View Abstract
131. Evaluation of brain activity in FDG PET studies. J Comput Assist Tomogr. 1998 Nov-Dec; 22(6):953-61. View Abstract
132. Lag phase quantification for solid gastric emptying studies. J Nucl Med. 1996 Oct; 37(10):1639-43. View Abstract
133. Intermodality, retrospective image registration in the thorax. J Nucl Med. 1995 Dec; 36(12):2333-8. View Abstract
134. Quantitation of SPECT performance: Report of Task Group 4, Nuclear Medicine Committee. Med Phys. 1995 Apr; 22(4):401-9. View Abstract
135. Evaluation of emission-transmission registration in thoracic PET. J Nucl Med. 1994 Nov; 35(11):1777-80. View Abstract
136. Sensitivity, resolution and image quality with a multi-head SPECT camera. J Nucl Med. 1992 Oct; 33(10):1859-63. View Abstract
137. Biphasic solid and liquid gastric emptying in normal controls and diabetics using continuous acquisition in LAO view. Dig Dis Sci. 1992 May; 37(5):744-50. View Abstract
138. Calculation of a gallbladder ejection fraction: advantage of continuous sincalide infusion over the three-minute infusion method. J Nucl Med. 1992 Apr; 33(4):537-41. View Abstract
139. 3-D SPECT simulations of a complex 3-D mathematical brain model: effects of 3-D geometric detector response, attenuation, scatter, and statistical noise. IEEE Trans Med Imaging. 1992; 11(2):176-86. View Abstract
140. Improved detection of small cavernous hemangiomas of the liver with high-resolution three-headed SPECT. J Nucl Med. 1991 Nov; 32(11):2086-91. View Abstract
141. Three-dimensional SPECT simulations of a complex three-dimensional mathematical brain model and measurements of the three-dimensional physical brain phantom. J Nucl Med. 1991 Oct; 32(10):1923-30. View Abstract
142. Digital image processing of radiation therapy portal films. Comput Med Imaging Graph. 1989 May-Jun; 13(3):227-33. View Abstract
143. Left anterior oblique projection and peak-to-scatter ratio for attenuation compensation of gastric emptying studies. J Nucl Med. 1989 Feb; 30(2):233-9. View Abstract
144. Characterization of the rotating display. Invest Radiol. 1988 Sep; 23(9):692-4. View Abstract
145. Renal scans in pregnant transplant patients. J Nucl Med. 1988 Aug; 29(8):1364-7. View Abstract
146. The effect of the Garren-Edwards Gastric Bubble on solid and liquid gastric emptying. Clin Nucl Med. 1988 Aug; 13(8):586-9. View Abstract
147. Comparison of bone mineral density in both hips. Radiology. 1988 Apr; 167(1):151-3. View Abstract
148. Hepatic visualization on iodine-131 whole-body thyroid cancer scans. J Nucl Med. 1987 Sep; 28(9):1408-11. View Abstract
149. 99mTc-glucoheptonate for quantitation of differential renal function. AJR Am J Roentgenol. 1987 May; 148(5):889-93. View Abstract
150. Detection efficiency of a high-pressure gas scintillation proportional chamber. Med Phys. 1987 Jan-Feb; 14(1):115-23. View Abstract
151. Impact of radiocontaminants in commercially available iodine-123: dosimetric evaluation. J Nucl Med. 1986 Mar; 27(3):428-32. View Abstract
152. Energy resolution in a high-pressure gas scintillation proportional chamber. Med Phys. 1986 Jan-Feb; 13(1):25-34. View Abstract
153. Thallium/technetium functional imaging of the thyroid and parathyroid. A case report. Clin Nucl Med. 1985 Dec; 10(12):865-7. View Abstract
154. The feasibility of epidemiologic studies of cancer in residents near the Rocky Flats Plant. Health Phys. 1982 Jan; 42(1):65-8. View Abstract
155. Choosing populations to study the health effects of low-dose ionizing radiation. Am J Public Health. 1981 Nov; 71(11):1247-52. View Abstract
Show All Publications Show Fewer Publications